PD Dr. rer. soc. Caterina Breitenstein

CBreitenstein.png

Antragstellerin, Lokale Projektleiterin FCET2EC

Department für Neurologie - Klinik für Allgemeine Neurologie - Universitätsklinikum Münster

Kontakt

Email:     caterina.breitenstein[at]uni-muenster.de

Fax:         + 49 (0) 251  834 4441

 

Curriculum Vitae

Akademischer Werdegang / Academic Degrees

2008
Priv.-Doz., Cognitive Neurosicence, University of Münster

1996
Dr. rer. soc. [Ph.D.], Neuropsychology, University of Tübingen

1992
Dipl.-Psych. [M.A.], Clinical Psychology, University of Tübingen

1988
Pre-Diploma [B.A.], Psychology, University of Marburg

 

Beruflicher Werdegang / Occupational Career, Lecturing

2004 - today
Senior Scientist (tenured), Neurology, University of Münster

2001 - 2003
Senior Research Fellow, Neurology, University of Münster

2000
Senior Research Fellow, Psychology, University of Trier

1997 - 1999
Postdoctoral Fellow, University of Southern California, Los Angeles

1996 - 1997
Assistant Professor (C1), Medical Psychology, University of Tübingen

1992 - 1996
Scientific Assistant, Medical Psychology, University of Tübingen

1989 - 1992
Research Assistant, Clinical Psychology, University of Tübingen

Stipendien, Preise, Eingeworbene Fördermittel / Fellowships, Awards, Funding

2017

Research Prize of the German Society for Neurotraumatology and Clinical Neurorehabilitation (DGNR)

2012 - 2015

Principal investigator of the national multicenter clinical trial "From controlled experimental trial to everyday communication: How effective is intensive aphasia therapy under routine clinical conditions?" funded by the BMBF

2005 - 2010
Research grant „Dopaminergic potentiation of language learning: Which brain structures and mechanisms are involved?” (Knecht, Breitenstein, Pantev), Volkswagen-Stiftung

2005 - 2009
Research grant „Dopaminergic improvement of recovery from aphasia” (Breitenstein, Zwitserlood, Deppe) as part of the BMBF consortium „Dopaminergic enhancement of learning, memory and recovery“ (speaker: Prof. S. Knecht)

2004 - 2007
Research grant „Dopaminergic improvement of learning“ (Knecht/Breitenstein), IZKF Münster

2005
Intramural bonus grant for acquiring extramural funding, Innovative Medizinische Forschung, University Hospital Münster

2000 - 2003
(Intramural) Research grant „Improved language acquisition by d-amphetamine: a model für language recovery in aphasia“, Innovative Medizinische Forschung, University Hospital Münster

1997 - 1999
2-year postdoctoral fellowship (German Research Society/DFG)

1997
Research grant (Pharmacia & Upjohn, California)

1992 - 1994
2-year predoctoral fellowship (Landesgraduierten-Förderungsprogramm, Baden-Württemberg)

Fünf relevante Publikationen der letzten fünf Jahre / Five relevant publications of the past five years

Breitenstein, C., Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E. B., Haeusler, K. G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., de Langen, E., Rocker, R., Wigbers, F., Rühmkorf, C., Hempen, I., List, J., & Baumgaertner, A. with the FCET2EC study group (2017). Intensive speech and language therapy in patients with chronic aphasia after stroke: a randomised, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet, 389, 1528–38. http://dx.doi.org/10.1016/S0140-6736(17)30067-3;

Please additionally refer to: Breitenstein, C., Martus, P., Willmes, K., Ziegler, W., & Baumgaertner, A. (2017). Intensive speech and language therapy after stroke - Authors' reply. Lancet, 390(10091), 228-229.

Breitenstein, C., & Baumgärtner, A. mit der FCET2EC Autorengruppe: Grewe, T., Flöel, A., Ziegler, W., Springer, L., Martus, P., Huber, W., Willmes, K., Ringelstein, E. B., Haeusler, K. G., Abel, S., Glindemann, R., Domahs, F., Regenbrecht, F., Schlenck, K.-J., Thomas, M., Obrig, H., de Langen, E., Rocker, R., Wigbers, F., Rühmkorf, C., Hempen, I., List, J. (2017). Wie wirksam ist intensive integrative Sprachtherapie nach einem Schlaganfall? Sprachtherapie aktuell: Forschung - Wissen -Transfer: Schwerpunktthema: Intensive Sprachtherapie (4)1: e2017-06; http://sprachtherapie-aktuell.de/files/e2017-06_Breitenstein_Baumgaertner.pdf; Zugriff am 30.01.2018.

Liepert, J., Breitenstein, C. (2016). Neues zur Neurorehabilitation: Motorik und Sprache [New developments in neurorehabilitation: motor system and language]. Nervenarzt. doi:10.1007/s00115-016-0239-1 (invited CME contribution).

Breitenstein, C., Korsukewitz, C., Baumgärtner, A., Flöel, A., Zwitserlood, P., Dobel, C., Knecht, S. (2015). L-dopa does not add to the success of high-intensity language training in aphasia. Restorative Neurology and Neuroscience, 33, 115-120.

Baumgaertner, A., Grewe, T., Ziegler, W., Floel, A., Springer, L., Martus, P., & Breitenstein, C. (2013). FCET2EC (From controlled experimental trial to=2 everyday communication): How effective is intensive integrative therapy for stroke-induced chronic aphasia under routine clinical conditions? A study protocol for a randomized controlled trial. Trials, 14, 308. http://www.trialsjournal.com/content/14/1/308; Zugriff am 30.01.2018.